… option for acute pain management, we had little experience with this aproach at our clinic
(Anderson et al, 2017). This strategy was efficacious, safe, and straightforward for the patient. …

… is the first analysis of acute pain management strategies in a veteran population chronically
receiving long-term buprenorphine or buprenorphine/naloxone. The findings herein expand …

… pain and OUD, who within 2 days of microdosing induction described moderate pain
relief … Within 7 days of initiation, the patient was stabilized on 12 mg SL buprenorphine/naloxone …

… that maintaining buprenorphine does not lead to inferior pain control and highlight the
potential risks of relapse and overdose for patients whose buprenorphine treatment is disrupted. …

… Buprenorphine-only formulations (without naloxone) are more vulnerable to abuse potential
because they can be injected without precipitation of withdrawal symptoms. Patients who …

… and indicators of efficacy in pain control from approximately six years of High-Risk Pain …
of buprenorphine/naloxone as a safe and effective part of comprehensive pain management in …

… Jones et al (12) reported good pain control after caesarean section using patient-… Pain
control outcomes for outpatient breast surgery using additional doses of buprenorphinenaloxone (…

… The current study investigated the effect of buprenorphine/naloxone (BuNa) rotation on
opioid misuse, craving, psychiatric symptoms and pain in patients with CNCP and OUD. Forty-…

… , acute pain management in patients with a history of opioid abuse or dependence while on
buprenorphine-naloxone is … pain management will likely not be effective. The high affinity of …

… after four weeks of treatment would be greater in the … versus buprenorphine/naloxone
treatment arm. Third, among those with pain at the beginning of the trial, is improvement in pain at …